相关实验视频

Updated: Jun 16, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

调节巨细胞介导的编程细胞去除:癌症治疗的一个有吸引力的策略

Zhenzhen Li¹, Bingqian Han², Menghui Qi²

¹Henan International Joint Laboratory of Prevention and Treatment of Pediatric Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou University, Zhengzhou 450018, China; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.

Biochimica et biophysica acta. Reviews on cancer

|August 16, 2024

概括

巨细胞中介编程细胞去除 (PrCR) 平衡了"吃我"和"不要吃我"信号,以保持组织健康. 准这些信号为有效的抗瘤治疗提供了一个有希望的策略.

科学领域:

免疫学和癌症生物学
细胞生物学细胞生物学
分子生物学分子生物学

背景情况:

巨介导的编程细胞去除 (PrCR) 对于组织稳定至关重要,它依赖于亲细胞 ("吃我") 和抗细胞 ("不要吃我") 信号的平衡.
瘤发生和进展与失调的PrCR有关,瘤微环境利用CD47/SIRPα等信号来逃避免疫检测.
有效的PrCR诱导需要克服瘤微环境中的免疫逃生机制.

研究的目的:

综合审查PrCR激活和抑制信号分子及其相互作用.
通过PrCR调制突出调节免疫功能的分子机制.
讨论针对PrCR的瘤治疗的进展和挑战.

主要方法:

关于PrCR信号通路的文献审查.
分析"吃我"和"不要吃我"信号之间的分子相互作用.
与PrCR相关的华堡效应的检查.

主要成果:

确定了关键的PrCR激活分子 (CRT,PS,Annexin1,SLAMF7) 和抑制分子 (CD47/SIRPα,MHC-I/LILRB1,CD24/Siglec-10,等等). ) 的情况.
在瘤微环境中调节PrCR的阐明的分子机制.
总结了关于激活PrCR的瘤治疗策略的当前研究.

结论:

针对PrCR信号的平衡提供了一个新的抗瘤策略.
了解PrCR的分子调节剂对于开发有效的癌症治疗非常重要.
需要进一步的研究来克服挑战,并优化PrCR向癌症治疗.

关键词:

巨细胞是一个巨细胞.发细胞症 (phagocytosis) 是一种致死细胞的发生.编程细胞去除编程细胞去除癌症治疗疗法癌症治疗

更多相关视频

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment

Published on: November 23, 2017

In Vitro Assay to Study Tumor-macrophage Interaction

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

相关概念视频

Phagocytosis of Apoptotic Cells

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.